(EDIT) Editas Medicine complete technical analysis [charts+indicators] | Buy/Sell Editas Medicine | (EDIT) share price targets
Complete technical analysis of Editas Medicine (EDIT) by charts plus indicators, forecast predictions and share price targets for Editas Medicine (EDIT)
Editas Medicine trades in USA in Health Care sector.
Showing technical analysis as on 2025-03-05 View latest technical analysis
10 day averaged volume of Editas Medicine is 10521000
| Date | Daily Closing Price | Open | High | Low | Volume |
| 05 Wed Mar 2025 | 2.04 | 1.85 | 2.25 | 1.83 | 0.861 times |
| 04 Tue Mar 2025 | 1.76 | 1.73 | 1.81 | 1.65 | 0.269 times |
| 03 Mon Mar 2025 | 1.77 | 1.97 | 1.97 | 1.75 | 0.233 times |
| 28 Fri Feb 2025 | 1.92 | 1.78 | 1.92 | 1.72 | 0.354 times |
| 27 Thu Feb 2025 | 1.83 | 1.84 | 2.29 | 1.80 | 0.741 times |
| 26 Wed Feb 2025 | 1.84 | 1.89 | 1.95 | 1.82 | 0.166 times |
| 25 Tue Feb 2025 | 1.86 | 1.92 | 1.98 | 1.80 | 0.292 times |
| 24 Mon Feb 2025 | 2.01 | 1.89 | 2.16 | 1.75 | 0.73 times |
| 21 Fri Feb 2025 | 1.92 | 2.40 | 2.40 | 1.89 | 0.9 times |
| 20 Thu Feb 2025 | 2.06 | 2.81 | 2.86 | 2.02 | 1.572 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 2.2 as stoploss in an intra day sell trade for a target of 1.7. However, stock will show a bullish move above 2.2.
Share price targets for Editas Medicine (EDIT)
| Target Type | Value |
| Downside Target | 1.12 |
| Downside Target | 1.16 |
| Downside Target | 1.22 |
| Downside Target | 1.40 |
| Downside Target | 1.48 |
| Downside Target | 1.57 |
| Downside Target | 1.65 |
| Downside Target | 1.72 |
| Upside Target | 2.14 |
| Upside Target | 2.25 |
| Upside Target | 2.29 |
| Upside Target | 2.37 |
| Upside Target | 3.30 |
| Upside Target | 3.40 |
Intraday share price targets for Editas Medicine (EDIT)
| Target Type | Value |
| Downside Intraday Target | 1.71 |
| Downside Intraday Target | 1.38 |
| Upside Intraday Target | 2.31 |
| Upside Intraday Target | 2.58 |
| Downside Intraday Target | 1.98 |
Weekly technical analysis of Editas Medicine (EDIT)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 05 Wed Mar 2025 | 2.04 | 1.97 | 2.25 | 1.65 | 0.597 times |
| 28 Fri Feb 2025 | 1.92 | 1.89 | 2.29 | 1.72 | 0.28 times |
| 21 Fri Feb 2025 | 1.92 | 1.41 | 3.30 | 1.41 | 5.77 times |
| 14 Fri Feb 2025 | 1.38 | 1.25 | 1.48 | 1.12 | 2.27 times |
| 07 Fri Feb 2025 | 1.25 | 1.26 | 1.40 | 1.22 | 0.812 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Editas Medicine (EDIT)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 05 Wed Mar 2025 | 2.04 | 1.97 | 2.25 | 1.65 | 0.109 times |
| 28 Fri Feb 2025 | 1.92 | 1.26 | 3.30 | 1.12 | 2.5 times |
| 31 Fri Jan 2025 | 1.31 | 1.27 | 1.57 | 1.12 | 1.01 times |
| 31 Tue Dec 2024 | 1.27 | 2.16 | 2.37 | 1.16 | 1.052 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Editas Medicine (EDIT)
Price action analysis of Editas Medicine ( (EDIT) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Editas Medicine ( (EDIT) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Editas Medicine ( (EDIT) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Editas Medicine ( (EDIT) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Editas Medicine stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Editas Medicine in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Editas Medicine Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Editas Medicine in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Editas Medicine is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.95 and Editas Medicine (EDIT) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Editas Medicine (EDIT) stock. Volume based technical analysis of Editas Medicine (EDIT) stock is negative.
Editas Medicine Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Editas Medicine ( (EDIT) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Editas Medicine ( (EDIT) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Editas Medicine ( (EDIT) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Editas Medicine ( (EDIT) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Editas Medicine stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Editas Medicine in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Editas Medicine Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Editas Medicine in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Editas Medicine is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.95 and Editas Medicine (EDIT) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Editas Medicine (EDIT) stock. Volume based technical analysis of Editas Medicine (EDIT) stock is negative.
Editas Medicine Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.